Gene Query: SPATS2L

Dataset Description Geneva Score
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 86.52
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 86.52
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 86.13
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 86.13
Overexpression of NFIB and YBX1 in MCF-7 cells 56.68
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 56.55
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 54.77
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 54.2
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 53.19
Gene Expression Profiling of SPOP Knocked Down Cell 48.7
Differential gene expression profiles in imatinib-resistant cell lines 47.26
MARS Seq data from human cortical organoids 43.35
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 41.65
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 41.65
RNA-Seq from early time points in the kidney differentiation protocol 40.97
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 40.56
RNA sequencing analysis of human embryonic stem cells and axial progenitors 39.37
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 37.81
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 37.81
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 37.33
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 36.59
Effects of rFVIIIFc on human macrophages 36.25
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 36.24
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 36.05
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 35.85
MYCi975 regulates MYC target genes 34.76
Differential expression of genes in AD169-infected MRC5. 33.67
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 32.95
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 31.66
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 30.93
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 30.52
Macrophage Ad5f35 M2 Challenge 30.17
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 29.63
Knockdown of ADNP in HCT116 colon cancer cells 29.31
IDH3a KO RNA-seq 29.26
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 29.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 28.75
Peptidomimetic blockade of MYB in acute myeloid leukemia 28.57
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 28.57
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 28.04
RNAseq Analysis in glioblastoma cells treated with Mepazine 27.15
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 27.03
U2AF1 mutations alter splice site recognition in hematological malignancies 26.97
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 26.75
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 26.67
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 26.57
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 26.55
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 26.16
The Genomic Landscape of Atypical Fibroxanthoma 25.22
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 24.83
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 24.13
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 23.83
Transcriptome analysis of kidney organoids 23.33
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 23.07
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 22.99
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 22.9
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 22.88
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 22.8
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 22.8
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 22.58
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 22.53
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 22.51
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 22.44
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 22.41
Paxillin regulates genomic networks in prostate cancer [LNCaP] 22.41
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 21.84
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 21.76
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 21.6
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 21.59
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 21.58
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 21.58
RNA sequencing of BT142 and TS603 cell lines 21.52
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 21.52
Primate transcript and protein expression levels evolve under compensatory selection pressures 21.34
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 21.14
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 21.01
Identifying the molecular mode of action of itraconazole in colorectal cancer 20.99
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 20.73
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 20.73
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 20.46
Silencing p300 in MCF7 cells to study expression and alternative splicing 19.33
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 19.23
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 19.23
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 18.83
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 18.79
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 18.7
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 18.68
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 18.54
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 18.49
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 18.49
MEIS1 regulates hematopoiesis in hPSCs 18.48
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 18.32
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 18.26
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 18.26
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 18.26
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 18.19
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 18.19
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 17.95
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 17.93
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 17.89
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 17.81
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 17.51
BI Human Reference Epigenome Mapping Project 17.48
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 17.41
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 17.29
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 17.19
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 17.14
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 17.01
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 16.94
snRNAs as regulators of alternative splicing 16.94
RNA-seq analysis of RALD iPSCs after in vitro differentiation 16.77
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 16.7
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 16.64
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 16.64
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 16.61
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 16.42
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 16.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 16.2
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 16.2
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 15.76
MCF-7 as a model for functional analysis of breast cancer risk variants 15.7
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 15.56
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 15.31
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 15.17
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 15.17
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 15.12
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 15.08
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 15.08
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 15.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 15.03
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 15.03
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 14.99
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 14.98
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 14.98
Interaction between mitoNEET and NAF-1 in cancer cells 14.83
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 14.7
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 14.67
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 14.67
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 14.57
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 14.51
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 14.5
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 14.45
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 14.25
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 14.21
The role of FAM46C in myeloma cells [sequencing] 14.2
The role of FAM46C in myeloma cells 14.2
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 14.11
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 14.03
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 13.98
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 13.95
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 13.95
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 13.76
MCF10A H-Ras RNA-Seq 13.72
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 13.72
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 13.65
RNAseq analysis of ESRP regulated splicing events in prostate cancer 13.65
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 13.61
Region-specific Innate Antiviral Responses of the Human Epididymis 13.5
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 13.47
Macrophage Ad5f35 PhenoMap 13.39
PNET animal model: new insights (II) 13.37
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 13.36
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 13.25
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 13.25
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 13.19
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 13.15
Next Generation Sequencing of human SMA and healthy control Motor Neurons 13.13
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 12.94
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 12.88
RNA-seq analyses of human prostate cancer cells 12.85
Gene expression profile in breast cancer cell lines using RNA sequencing 12.84
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 12.81
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 12.81
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 12.78
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 12.75
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 12.7
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 12.66
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 12.64
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 12.62
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 12.62
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.47
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.47
MARCKS and lnc-MARCKS act as inflammation regulators 12.38
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.26
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.26
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.26
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 12.14
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 12.14
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 12.14
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 12.0
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 11.96
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 11.87
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 11.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 11.78
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 11.78
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 11.69
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 11.69
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 11.66
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 11.63
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 11.62
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 11.59
Transcriptome profiling of Normal and Cancerous Prostate Cells 11.57
LIN28A modulates splicing and gene expression programs in breast cancer cells 11.55
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 11.55
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 11.54
Nutritional control of protein translation 11.53
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.48
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 11.47
BET bromodomain inhibition 11.47
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 11.45
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 11.45
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 11.43
Expression profiles of the four human major ectodermal lineages 11.22
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 11.18
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 11.08
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 11.08
RNA-seq analysis and shRNA screen of breast cancer 11.08
RNA-seq analysis of breast cancer 11.08
Lineage specific differentiation is influenced by state of human pluripotency 11.07
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 11.07
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 11.07
An integrative analysis of non-coding regulatory DNA variations associated with autism 11.06
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 11.05
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 11.05
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 11.01
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 10.98
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 10.91
Genome-wide chromatin analysis of Ewing sarcoma 10.86
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 10.86
Regionally specified human pluripotent stem cell-derived astrocytes 10.86
mRNA expression in human DAOY cells 10.85
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 10.83
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 10.73
RIG-I and MDA5 fRIP during KSHV lytic reactivation 10.66
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 10.65
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 10.64
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.61
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.58
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 10.58
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.57
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 10.54
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 10.54
RNA expression following TMPRSS11B overexpression or depletion 10.5
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 10.49
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 10.49
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 10.49
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 10.48
Epigenome regulation during epidermal lineage commitment [RNA-seq] 10.47
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 10.46
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 10.46
Neonatal and adult human testis defined at the single-cell level 10.46
Control of prostate tumour growth by the long non-coding RNA GHSROS 10.41
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 10.4
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.39
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.27
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.27
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 10.27
RNA-seq analysis of the human fetal kidney. 10.25
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 10.2
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 10.17
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.15
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 10.12
RNA-seq of naive and primed ES cells (NHSM) 10.1
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 10.07
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.04
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.03
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 10.03
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 10.03
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 9.98
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 9.88
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 9.88
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 9.85
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 9.85
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 9.85
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 9.85
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 9.77
Gene expression profile of multiple myeloma cell lines treated with CB-5083 9.76
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.73
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.66
NHLRC1 re-expression in cancer cells 9.65
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 9.64
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 9.56
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 9.56
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 9.49
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 9.49
hESC neural differentiation 9.48
RNA-seq analysis of gene expression patterns during hESC neural differentiation 9.48
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 9.46
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 9.43
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 9.43
RNA-seq analyisis of PUM2 knockout cells 9.42
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 9.41
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 9.37
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 9.36
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 9.32
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 9.25
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 9.25
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 9.21
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 9.2
Global gene expression profile of dasatinib-resistant RCH-ACV cells 9.08
DIGIT regulates endoderm differentiation of human embryonic stem cells 9.08
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.05
Differential gene expression of human melanoma cells [RNA-seq] 9.05
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 9.04
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 9.01
Metabolism as an early predictor of DPSCs aging 9.0
Transcriptome of U251 cells overexpression complement component 7 8.96
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 8.9
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 8.88
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 8.85
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 8.83
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 8.79
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 8.7
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 8.68
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 8.63
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 8.61
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.53
RNA Seq of HMVEC under hypoxia 8.53
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 8.45
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 8.41
Transcriptome Profiling of Human Primary Monocytes 8.39
CDK12 mediated transcriptional regulation in U2OS cells 8.37
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 8.33
CD86 regulates a pro-survival signal in myeloma cells 8.23
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 8.21
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 8.21
An optimization system for isolating and sequencing of single human colon cancer cells 8.2
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 8.16
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 8.15
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 8.15
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 7.95
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 7.95
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 7.94
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.92
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 7.88
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 7.82
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 7.79
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.58
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 7.5
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 7.48
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 7.46
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 7.44
MicroRNA targetome analysis during HCMV infection 7.4
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 7.17
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 7.12
Gene expressions of H9s in different culture systems 7.11
RNA-seq of naive and primed ES cells 7.08
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 7.02
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.0
Capturing the Interactome of Newly Transcribed RNA 7.0
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.94
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 6.88
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.82
Triple vectors expand AAV transfer capacity in the retina 6.72
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 6.64
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 6.57
Functional astrocytes differentiated from hiPSCs 6.56
Fusion discovery in breast cancer cell line 6.46
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 6.42
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 6.35
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 6.32
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 6.22
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 6.16
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.09
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.03
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 5.92
RNA seq_PDX2_SHP099 5.91
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 5.85
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 5.85
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 5.81
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 5.71
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.6
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.57
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 5.53
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 5.25
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.24
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.24
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.19
Human Treg NaCl stimulation 5.16
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.08
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.07
Clinker: visualizing fusion genes detected in RNA-seq data 5.02
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 4.89
Finding missing proteins from epigenetically manipulated human cells 4.81
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.74
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.67
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.61
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.56
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.56
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 4.46
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 4.45
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.44
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.44
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.36
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.35
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.28
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.25
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.23
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.03
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.95
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 3.94
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.83
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.83
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.83
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 3.79
BASP1 modifies the Tamoxifen response 3.78
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.73
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 3.72
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.68
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.68
Human ovarian granulosa cell transcriptome 3.65
Epigenome regulation during epidermal lineage commitment 3.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.59
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.59
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 3.48
Analysis of transcriptional regulation by Myt1 and Myt1l 3.47
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.45
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.45
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.44
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.38
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.37
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.19
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.19
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.11
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.07
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.95
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.88
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.87
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.83
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 2.77
Effect of BMP inhibition or stimulation of primary human keratinocytes 2.69
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 2.69
iPSC derived motor neuron cultures from C9ORF72 carriers 2.64
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 2.64
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.6
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.53
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.47
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 2.43
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.36
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.35
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.3
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.3
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 2.12
RNA-Seq in PWS iPSC-derived neurons 2.07
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.06
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.02
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.02
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 2.01
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 2.0
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.0
Human Treg IFNg/IL-10 subpopulations 1.89
mRNA sequencing of oropharyngeal cancer cell lines 1.87
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.83
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.78
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.71
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.66
Gene expression analysis of breast cancer cell-lines 1.66
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.66
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.63
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.46
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.43
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 1.43
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.36
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.36
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.33
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.32
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.29
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.16
FOXP2's impact on the primate transcriptome 1.15
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.08
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.08
Gene expression profile of CRC-derived HILEC 1.06
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.06
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.06
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.98
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.9
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.85
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.77
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.56
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.53
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.44
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.44
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.43
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 0.41
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.41
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.38
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.38
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.33
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.17
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.17
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.16
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.16
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.09
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.05
MHC Transcriptomic landscape at haplotype-specific resolution 0.02
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.01
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation